Arbutus Biopharma
phase a clinical trial | Arbutus Biopharma
Company
Deck Type
Sector
Industry
Deck date
May 2023
Slide
17 of 28
Similar slides by Arbutus Biopharma
See diffirences between slides (animation)
Investor Presentation
January 2024
phase a clinical trial | Arbutus Biopharma
Investor Presentation
November 2023
phase a clinical trial | Arbutus Biopharma
Investor Presentation
October 2023
phase a clinical trial | Arbutus Biopharma
Investor Presentation
August 2023
phase a clinical trial | Arbutus Biopharma
Related slides by other companies
Nuvalent
Investor Presentation
April 2024
lated cone program status pivotal data naive and first approved product study for phase ongoing with registrational intent for patients with execute on global registrational strategies additional discovery research programs ongoing mission bringing new best in class medicines to patients with cancer treated alk planned development in naive setting phase ongoing with registrational intent for patients with study for alk planned phase initiation in i he | Nuvalent
Exscientia
Results
March 2024
elucidate phase ongoing in advanced solid | Exscientia
Exscientia
Investor Presentation
August 2023
elucidate phase ongoing in advanced solid | Exscientia
Exscientia
Investor Presentation
October 2023
elucidate phase ongoing in advanced solid | Exscientia
Other recent decks by Arbutus Biopharma
See all presentations (7 decks)
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
October 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io